Division Director for "Molecular and Microbial Diagnostics and Development", Department of Laboratory Medicine, Geisinger
BIOGRAPHY
Speaker
Event Date & Time
Date: September 16, 2020
Time: 10:00am (PDT), 1:00pm (EDT)
Abstract
Individuals infected with COVID-19 can experience mild symptoms and recover while others can experience more serious illness and may require hospital care.
COVID-19 clinical symptoms range from mild acute respiratory infection (ARI), severe acute respiratory infection (SARI) with progressive organ failure, sepsis and acute respiratory distress syndrome (ARDS).1 It has become clear that sepsis is a common complication in COVID-19 patients and an important risk factor for increased mortality. In a recent multicenter study, the risk factors associated with in-hospital deaths of 191 patients were analyzed and sepsis was the most frequently observed complication (100% of the non-survivors), followed by respiratory failure (98%), ARDS (93%), septic shock (70%) and heart failure (52%).2 Researchers are still investigating the pathogenic origin of sepsis in COVID-19 patients to understand whether it is directly caused by SARS-CoV-2 virus and/or a secondary source (bacterial, viral or fungal).
Learning Objectives
- Compare and contrast viral sepsis with focus on sepsis symptoms caused by SARS-CoV-2
- The role of rapid testing for COVID-19 to support blood culture stewardship
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...